Articles By Jack Cush, MD
Improving the ACR – Big Meeting Experience
Our experts say you should: Plan the night before, use the ACR meeting App, work in groups, be involved in social media and, have fun! What's your advice on how to best attend the ACR meeting?
Read Article
BMS and Celgene Merge as Amgen Buys Otezla
Bristol-Myers Squibb (BMS) has completed its $74 billion acquisition of Celgene. With the acquisition complete, Celgene is now a wholly-owned subsidiary of BMS. The combined companies have nine products with more than $1 billion in annual sales.
Read Article
RheumNow Podcast –Favorites of ACR 2019 (11.22.19)
Dr. Jack Cush recaps standout presentations and information from ACR 2019 held in Atlanta November 9-12, 2019.
Read Article
ACR 2019 - Report From Day 3 (Tuesday)
Here's my summary of key studies presented Tuesday. Tofacitinib in Polyarticular JIA
Read Article
Psoriatic Arthritis at ACR 2019
Below are several of the highlight studies in psoriatic arthritis (PsA) presented at the ACR 2019 annual meeting in Atlanta.
Read Article
ACR 2019 - Report From Day 2 (Monday)
Monday was another full day of sessions and studies here in Atlanta. Following is my roundup of day two.The Safety of Methotrexate
Read Article
ACR 2019 – Best of the Plenary Sessions
The ACR Plenary Sessions featured some of the best research presented on Sunday, Monday, and Tuesday in Atlanta. Here are my seven notable highlights from the Plenaries.
Read Article
ACR 2019 - Report from Day One (Sunday)
Sunday was the first full day of scientific sessions at the 2019 ACR/ARP meeting in Atlanta. Yesterday we shared our initial news articles, videos and more with you. Following is my roundup of day one. Delays in Diagnosis
Read Article
RheumNow Podcast – ACR 2019 Round Up (11.15.19)
Dr. Jack Cush presents his favorite abstracts and presentations from Rheumatology Round Up and ACR 2019.
Read Article
RheumNow Podcast – Better Ways to Treat Gout (11.8.19)
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.
Read Article
